Quanta Receives FDA 510(k) Clearance for the SC+ Hemodialysis System Setting the Stage for US Market Launch Quanta Receives FDA 510(k) Clearance for the SC+ Hemodialysis System Setting the Stage for US Market Launch Alcester, Warwickshire, UK, 8 January 2021: Quanta Dialysis Technologies Ltd (“Quanta”...

Quanta Appoints John S. Lipman as President of North America Quanta Appoints John S. Lipman as President of North America Alcester, Warwickshire, UK, 24 November 2020: Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a British medical...